Neos Therapeutics

About:

Neos Therapeutics is an oral drug delivery company developing controlled time-release technologies.

Website: http://www.neostx.com

Top Investors: Hercules Capital, Deerfield, CMEA Capital, Delaware Street Capital, Presidio Partners

Description:

The Neos Therapeutics team is dedicated to creating high-quality products and partnering with pharmaceutical and consumer healthcare companies to address key medical needs. Neos Therapeutics’ research and development (R&D) and fully integrated state of the art, FDA approved manufacturing facility is located in the Dallas/Fort Worth area.

Total Funding Amount:

$204M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Grand Prairie, Texas, United States

Founded Date:

2008-01-01

Contact Email:

inquiry(AT)neostx.com

Founders:

Josh Disbrow

Number of Employees:

101-250

Last Funding Date:

2017-02-01

IPO Status:

Public

Industries:

© 2025 bioDAO.ai